Phase 4 N=50 PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK
Actinic Keratoses
Primary: Overall Subject Satisfaction the Day of Treatment After Daylight Session — 47 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=19 Investigation of Hyperhidrosis Treatment Using the Nd: YAG 1440nm Wavelength Laser
HYPERHIDROSIS
Primary: Percentage of Photographs Identified Accurately — 84.8 % of photographs identified correctly
N/A N=29 Evaluation of the MJGS Following Radiesse (+) Injection Into the Jawline
Volume Loss of the Jawline
Primary: Percentage of Jawlines Achieving Greater Than or Equal to (>=) 1-point Improvement on Merz Jawline Grading Scale (MJGS) at Week 4 — 92.1; 0; 92.1; 0 percentage of…
Phase 2 N=13 Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC: PRECISE Trial
Lung Cancer · Non-small Cell Lung Cancer
Primary: Objective Response by Response Evaluation Criteria in Solid Tumors (RECIST1.1) — 1; 4; 3; 2 Participants — p=0.05
Phase 4 N=169 Effect of Mu-opioid Receptor Genetics on 3 Doses of Spinal Morphine for Postoperative Analgesia After Cesarean Section
Postoperative Pain
Primary: Milligrams of Intravenous Morphine Used by Participant in First 24 Hours Postoperatively — 18; 14; 15 Milligrams
N/A N=16 Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema
Retinal Vein Occlusion · Diabetic Macular Edema
Primary: Best Corrected Visual Acuity (BCVA) by Early Treatment Diabetic Retinopathy Study (ETDRS) — -0.9; -2.0 ETDRS letters
Phase 2 N=50 A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients
Stem Cell Transplant Complications
Primary: Number of Participants With Primary Blood Stream Infections — 1; 2 Participants
N/A N=18 Production of a Device to Obtain Continuous Ambulatory Vestibular Assessment (CAVA) - Healthy Volunteer Trial
Optokinetic Nystagmus
Primary: Sensitivity and Specificity of a Computer Algorithm to Detect Artificially Induced Nystagmus — 99.1; 98.6 Percent
N/A N=39 Caries Prevention Products & Dentinal Hypersensitivity
Hypersensitivity
Primary: Dentinal Hypersensitivity — 1; 1; 0; 3 units on a scale — p=0.72
N/A N=118 DAILIES TOTAL1 Versus ACUVUE TruEye - Effects on the Biology of the Ocular Surface and Lid Margin
Soft Contact Lenses · Myopia
Primary: Desquamation Rate of Wearing Alcon DAILIES, Then AcuVue TruEye Contact Lenses — 53.86; 54.05 cells/min
N/A N=65 Post-market Clinical Study to Confirm Safety and Performance of PuraStat® for the Management of Bleeding in Vascular Surgery.
Vascular Anastomosis Surgery
Primary: Total Time-To-Haemostasis — 83 Secondes
N/A N=225 Impact of an Interprofessional Shared Decision-making and Goal-setting Decision Aid for Patients With Diabetes
Diabetes Mellitus
Primary: Decisional Conflict in Patients With Diabetes — 25.53; 23.56; 21.97; 21.10 score on a scale — p=0.0246
N/A N=257 Experience of Pain During Oocyte Retrieval- a Comparison Between Two Aspiration Needles
Infertility
Primary: Visual Analogue Scale — 21.0; 26.0 0-100 mm — p=0.04
N/A N=803 Promoting Successful Weight Loss in Primary Care in Louisiana
Obesity
Primary: Body Weight (Percent Change) — -4.99; -0.48 percent change
N/A N=537 Deliberate Ultraviolet Light Exposure to Get a Tan by Young Adult Sexual Minority Males
Sun Sensitivity
Primary: Outdoor Tanning Motives — 3.64; 3.81; 4.10; 4.29 score on a scale — p=0.02